Benzos, Sleep, Memory, Dementia
It’s been 3 years since BMJ (formerly The British Medical Journal) published “Benzodiazepine use and risk of Alzheimer’s disease: case-control study” (BMJ 2014; 349:g5205).
The main conclusion was that using benzodiazepines (“ben-zoe-dye-AIZE-uh-peenz” or BZDs or benzos, which include Klonopin/clonazepam, Xanax/alprazolam, Valium/diazepam, Ativan/lorazepam, Restoril/temazepam, and others) for more than 90 days resulted in an increased risk for dementia of the Alzheimer type after age 66.
We are certainly alerting our patients to this problem.
You must be logged in to post a comment.